ImmunityBio的Anktiva®逆转淋巴细胞减少症,延长对检查点疗法耐药的晚期非小细胞肺癌患者总生存期
ImmunityBio的Anktiva®逆转淋巴细胞减少症,延长对检查点疗法耐药的晚期非小细胞肺癌患者总生存期
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.